Barclays Boosts LifeStance Health Group (NASDAQ:LFST) Price Target to $7.00

LifeStance Health Group (NASDAQ:LFST) had its price target increased by Barclays from $6.00 to $7.00 in a research report sent to investors on Monday,Benzinga reports. Barclays currently has an underweight rating on the stock.

Separately, UBS Group cut their price target on LifeStance Health Group from $9.00 to $7.50 and set a “neutral” rating on the stock in a research note on Thursday, August 15th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, LifeStance Health Group presently has a consensus rating of “Hold” and an average target price of $8.42.

LifeStance Health Group Stock Down 2.4 %

Shares of NASDAQ LFST opened at $7.22 on Monday. The company has a quick ratio of 1.22, a current ratio of 1.32 and a debt-to-equity ratio of 0.19. The company has a market cap of $2.76 billion, a price-to-earnings ratio of -27.77 and a beta of 1.24. LifeStance Health Group has a 12-month low of $4.64 and a 12-month high of $9.20. The firm’s 50-day simple moving average is $6.97 and its 200 day simple moving average is $6.23.

LifeStance Health Group (NASDAQ:LFST) last released its quarterly earnings results on Thursday, November 7th. The company reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.07) by $0.05. LifeStance Health Group had a negative net margin of 7.90% and a negative return on equity of 6.66%. The business had revenue of $312.70 million for the quarter, compared to analysts’ expectations of $302.25 million. During the same period in the prior year, the firm earned ($0.17) earnings per share. LifeStance Health Group’s revenue was up 18.9% compared to the same quarter last year. On average, research analysts expect that LifeStance Health Group will post -0.22 earnings per share for the current fiscal year.

Insider Buying and Selling

In other LifeStance Health Group news, insider Ann Varanakis sold 5,269 shares of the stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $6.28, for a total value of $33,089.32. Following the transaction, the insider now owns 263,007 shares of the company’s stock, valued at approximately $1,651,683.96. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 6.60% of the stock is owned by insiders.

Institutional Investors Weigh In On LifeStance Health Group

Several hedge funds have recently bought and sold shares of the company. MetLife Investment Management LLC increased its position in shares of LifeStance Health Group by 14.3% in the 3rd quarter. MetLife Investment Management LLC now owns 80,422 shares of the company’s stock valued at $563,000 after buying an additional 10,084 shares in the last quarter. Townsquare Capital LLC bought a new stake in shares of LifeStance Health Group in the third quarter worth about $73,000. The Manufacturers Life Insurance Company raised its position in shares of LifeStance Health Group by 10.5% during the third quarter. The Manufacturers Life Insurance Company now owns 81,741 shares of the company’s stock worth $572,000 after purchasing an additional 7,798 shares during the period. Charles Schwab Investment Management Inc. lifted its holdings in shares of LifeStance Health Group by 36.9% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,104,453 shares of the company’s stock valued at $7,731,000 after purchasing an additional 297,723 shares in the last quarter. Finally, Landscape Capital Management L.L.C. grew its position in shares of LifeStance Health Group by 43.7% in the 3rd quarter. Landscape Capital Management L.L.C. now owns 367,935 shares of the company’s stock valued at $2,576,000 after purchasing an additional 111,894 shares during the period. 85.50% of the stock is currently owned by institutional investors and hedge funds.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.